Pharmx Technologies Limited (ASX:PHX)
| Market Cap | 54.62M -29.8% |
| Revenue (ttm) | 7.62M +4.1% |
| Net Income | -1.83M |
| EPS | -0.00 |
| Shares Out | 666.12M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 309,331 |
| Open | 0.0860 |
| Previous Close | 0.0860 |
| Day's Range | 0.0820 - 0.0860 |
| 52-Week Range | 0.0820 - 0.2000 |
| Beta | 0.33 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 27, 2026 |
About Pharmx Technologies
Pharmx Technologies Limited, together with its subsidiaries, engages in the technology and software development business in Australia and New Zealand. It offers Pharmx Gateway, an electronic ordering and invoicing solution; Pharmx Marketplace, an e-commerce ordering platform; and Pharmx Analytics, a solution that provides insights for suppliers and buyers. The company was formerly known as Corum Group Limited and changed its name to Pharmx Technologies Limited in October 2023. Pharmx Technologies Limited was incorporated in 1950 and is based in... [Read more]
Financial Performance
In fiscal year 2026, Pharmx Technologies's revenue was 7.62 million, an increase of 4.06% compared to the previous year's 7.32 million. Losses were -1.83 million, 591.7% more than in 2025.
Financial StatementsNews
Full Year 2026 Pharmx Technologies Ltd Earnings Presentation Transcript
Full Year 2026 Pharmx Technologies Ltd Earnings Presentation Transcript
Pharmx Technologies Earnings Call Transcript: H2 2026
FY 2026 saw strong revenue and recurring growth, led by Marketplace and analytics, with positive EBITDA despite increased investment. Strategic alliances, platform modernization, and AI initiatives set the stage for margin expansion and accelerated growth in FY 2027.
Pharmx Technologies Annual report: H2 2026
Pharmx Technologies has published its H2 2026 annual report on August 26, 2026.
Pharmx Technologies Earnings release: H2 2026
Pharmx Technologies released its H2 2026 earnings on August 26, 2026, summarizing the period's financial results.
Pharmx Technologies Slides: H2 2026
Pharmx Technologies has posted slides in relation to its H2 2026 quarterly earnings report, which was published on August 26, 2026.
Pharmx Technologies Slides: FY 2026
Pharmx Technologies has posted slides in relation to its FY 2026 quarterly earnings report, which was published on June 16, 2026.
Pharmx Technologies Earnings Call Transcript: H1 2026
Revenue grew 3% to AUD 3.9 million with strong Marketplace and New Zealand performance, positive EBITDA, and a major strategic partnership with Sigma Chemist Warehouse. Marketplace adoption and supplier integration surged, supporting future growth.
Pharmx Technologies Quarterly report: H1 2026
Pharmx Technologies has published its H1 2026 quarterly earnings report on February 24, 2026.
Pharmx Technologies Slides: H1 2026
Pharmx Technologies has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 24, 2026.
Pharmx Technologies Earnings release: H1 2026
Pharmx Technologies released its H1 2026 earnings on February 24, 2026, summarizing the period's financial results.